Skip to content

Postprandial Glycemic Response of Glucomeal as Pre-meal (before breakfast) in Type 2 Diabetic Patients

Postprandial Glycemic Response of Glucomeal as Pre-meal (before breakfast) in Type 2 Diabetic Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210429006
Enrollment
15
Registered
2021-04-29
Start date
2019-08-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes T2DM

Interventions

A whey protein-based energy drink was prepared using 100 g of a vanilla-flavored instant beverage containing 22% of whey protein concentrate with vitamins and minerals (GLUCOMEAL) dissolved in 400 g w
Experimental Dietary Supplement,Placebo Comparator Dietary Supplement
Glucomeal,Vanilla drink

Sponsors

Mega Lifesciences Public Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.BMI 18.5-30 kg-m2 2.Only stable oral hypoglycemic drugs for at least 2 months.

Exclusion criteria

Exclusion criteria: 1. Concomitant therapy insulin 2. Person with gastrointestinal disease, renal disease, liver disease, thyroid disease, cancer, cardiovascular disease 3. Pregnant or lactating females.

Design outcomes

Primary

MeasureTime frame
postprandial glycemic control Before taking intervention meal (-30 min). And at 0, 30, 60, 90, 120, 180 and 240 minutes after consume. Blood glucose,postprandial insulin response Before taking intervention meal (-30 min). And at 0, 30, 60, 90, 120, 180 and 240 minutes after consume. Insulin

Secondary

MeasureTime frame
postprandial active-GLP-1 response Before taking intervention meal (-30 min). And at 0, 30, 60, 90, 120, 180 and 240 minutes after consume. Active-GLP-1

Countries

Thailand

Contacts

Public ContactWantanee Kriengsinyos

Institute of Nutrition, Mahidol University

Pimnapanut.sri@gmail.com028002380

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026